Literature DB >> 19840786

In sickness and in health: Corneal epithelial stem cell biology, pathology and therapy.

M Notara1, A Alatza, J Gilfillan, A R Harris, H J Levis, S Schrader, A Vernon, J T Daniels.   

Abstract

Our window to the world is provided by the cornea on the front surface of the eye. The integrity and functionality of the outermost corneal epithelium is essential for vision. A population of limbal epithelial stem cells (LESCs) are responsible for maintaining the epithelium throughout life by providing a constant supply of daughter cells that replenish those constantly lost from the ocular surface during normal wear and tear and following injury. LESC deficiency leads to corneal opacification, inflammation, vascularization and discomfort (Daniels et al., 2001, 2007). Cultured LESC delivery is one of several examples of successful adult stem cell therapy in patients. The clinical precedence for use of stem cell therapy and the accessibility of the transparent stem cell niche make the cornea a unique model for the study of adult stem cells in physiological conditions as well as in disease. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840786     DOI: 10.1016/j.exer.2009.09.023

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  37 in total

1.  Establishment of an untransfected human corneal epithelial cell line and its biocompatibility with denuded amniotic membrane.

Authors:  Ting-Jun Fan; Bin Xu; Jun Zhao; Hong-Shou Yang; Rui-Xin Wang; Xiu-Zhong Hu
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

Review 2.  Concise review: identifying limbal stem cells: classical concepts and new challenges.

Authors:  Aaron W Joe; Sonia N Yeung
Journal:  Stem Cells Transl Med       Date:  2013-12-10       Impact factor: 6.940

3.  Suitability of human Tenon's fibroblasts as feeder cells for culturing human limbal epithelial stem cells.

Authors:  Gaia Scafetta; Eleonora Tricoli; Camilla Siciliano; Chiara Napoletano; Rosa Puca; Enzo Maria Vingolo; Giuseppe Cavallaro; Andrea Polistena; Giacomo Frati; Elena De Falco
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

4.  Limbal stem cell disease: Treatment and advances in technology.

Authors:  Hall F Chew
Journal:  Saudi J Ophthalmol       Date:  2011-05-24

5.  Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.

Authors:  Dhruv Sareen; Mehrnoosh Saghizadeh; Loren Ornelas; Michael A Winkler; Kavita Narwani; Anais Sahabian; Vincent A Funari; Jie Tang; Lindsay Spurka; Vasu Punj; Ezra Maguen; Yaron S Rabinowitz; Clive N Svendsen; Alexander V Ljubimov
Journal:  Stem Cells Transl Med       Date:  2014-07-28       Impact factor: 6.940

6.  Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells.

Authors:  Heidi Hongisto; Meri Vattulainen; Tanja Ilmarinen; Alexandra Mikhailova; Heli Skottman
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

7.  Restoring the cornea from limbal stem cells.

Authors:  Markus H Frank; Natasha Y Frank
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

8.  Limbal Basal Cell Density Decreases in Limbal Stem Cell Deficiency.

Authors:  Eric H Chan; Luxia Chen; Jian Yu Rao; Fei Yu; Sophie X Deng
Journal:  Am J Ophthalmol       Date:  2015-07-04       Impact factor: 5.258

9.  Human corneal stromal stem cells exhibit survival capacity following isolation from stored organ-culture corneas.

Authors:  Alvena K Kureshi; James L Funderburgh; Julie T Daniels
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-21       Impact factor: 4.799

10.  Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium.

Authors:  Sandhya M Sharma; Thomas Fuchsluger; Sajjad Ahmad; Kishore R Katikireddy; Myriam Armant; Reza Dana; Ula V Jurkunas
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.